[The state of shock].
D000138:Acidosis; D000311:Adrenal Glands / Q000503:physiopathology; D001337:Autonomic Agents / Q000627:therapeutic use*; D001809:Blood Viscosity; D001810:Blood Volume; D002196:Capillaries / Q000503:physiopathology; D002302:Cardiac Output; D002395:Catecholamines / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003911:Dextrans / Q000627:therapeutic use*; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D008099:Liver / Q000503:physiopathology; D010477:Perfusion; D012769:Shock / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology*; D013565:Sympatholytics / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D001337:Autonomic Agents; D002395:Catecholamines; D000697:Central Nervous System Stimulants; D003911:Dextrans; D013565:Sympatholytics; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents
Considérations sur l'état de shock.